Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

811 items
NEI logo.

Corticosteroids for First-Time Optic Neuritis Lowers Risk of Developing Multiple Sclerosis

December 8, 1993

Over half of all people with first-time optic neuritis, a vision-impairing inflammation of the optic nerve, will eventually develop multiple sclerosis (MS).
NEI logo.

Treatment for Retinitis Pigmentosa Reported

June 14, 1993

Most adults with blinding retinitis pigmentosa (RP) should take a daily, 15,000 IU vitamin A supplement, based on results from a large, randomized clinical trial published today in the Archives of Ophthalmology.
NEI logo.

ETDRS 5-Year Followup Data Released

March 9, 1993

The National Eye Institute reported today that current treatments for a common, sight-threatening complication of diabetes have proved 95 percent effective in maintaining vision, but 8,000 still go blind each year from this disease.
NEI logo.

Patient/Donor Blood Type Matching Improves Corneal Transplantation Outcome

October 14, 1992

Researchers report that donor-recipient tissue typing had no significant long-term effect on the success of corneal transplantation in a nationwide clinical study of over 400 patients at high risk for rejection.
NEI logo.

Oral Corticosteroids Alone Found Ineffective for Optic Neuritis

February 26, 1992

Although commonly used, oral corticosteroids alone are ineffective in treating optic neuritis, a debilitating inflammation of the optic nerve, and actually increase a person’s risk for future attacks.
NEI logo.

Foscarnet and Ganciclovir Compared as Treatment for CMV Retinitis

October 21, 1991

Results from a large, multicenter clinical trial show that patients with AIDS treated for cytomegalovirus (CMV) retinitis
Glaucoma and the optic nerve

Laser Therapy Show Promise As Alternative to Glaucoma Drugs

December 7, 1990

Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.
NEI logo.

Fluorouracil Improves Glaucoma Surgery Outcome

December 15, 1989

Louis W. Sullivan, Secretary of Health and Human Services, has announced results of a clinical trial demonstrating a 50 percent improvement in surgical control of glaucoma in patients at high risk for blindness.
Two boys smile at the camera. Asymmetric dark spots block parts of the image, representing vision loss from diabetic retinopathy.

Laser Treatment Highly Effective in Treating Diabetic Retinopathy

October 30, 1989

New findings from a nationwide clinical trial supported by theNational Eye Institute (NEI) provide further evidence that laser treatment is highly effective in preventing visual loss from diabetic eye disease.
NEI logo.

Freeze Treatment Reduces Blindness in Premature Infants

March 29, 1988

Briefly freezing a portion of the eye’s surface can protect many premature infants against blindness from retinopathy of prematurity (ROP), a disease that causes visual loss in 2,600 infants in the United States annually.